Physician profile
Kenneth D Root
NPI 1053353946
$248.93
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $177 · 2022: $16.44 · 2024: $55.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $55.12 | 2024 | |
| Indivior INC. | $41.09 | 2021 | |
| Abbvie INC. | $32.22 | 2021 | |
| Amgen INC. | $26.45 | 2021 | |
| Pear Therapeutics (US), INC. | $17.03 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.44 | 2022 | |
| Orexo US, INC. | $16.10 | 2021 | |
| Avanir Pharmaceuticals, INC. | $15.25 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.03 | 2021 | |
| Bardy Diagnostics, INC. | $14.20 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Root listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.